Topic: Labeling Transparency

Labeling Transparency comes up in 3 chapters across 3 episodes of The Higherside Chats Free Show, from April 2016 to September 2021.

April 2016 September 2021

Related topics

Carey Gillam | The Monsanto Papers, Glyphosate Damage, & Corrupted Science
• 53:35 - 55:56

Carey Gillam | The Monsanto Papers, Glyphosate Damage, & Corrupted Science

GMO Labeling Battles, Health Care Costs, Cheap Food Paradox

The food industry has spent millions to fight mandatory GMO labeling, opting instead for federal preemption and confusing compromise labels. While conventional, chemically-treated food appears cheaper at the register, the long-term costs in healthcare, lost productivity, and environmental damage amount to billions of dollars annually. Experts argue that the "cheapness" of industrial food is an illusion when factoring in the economic burden of chronic illness.

gmo labelingtransparencyhealth careeconomicstoxicology
Cosima Dannoritzer | Planned Obsolescence & The E-Waste Tragedy
• 32:25 - 36:48

Cosima Dannoritzer | Planned Obsolescence & The E-Waste Tragedy

Consumer Transparency, LED Bulb Market Shift

Advocates suggest that laws should require manufacturers to list the expected lifespan of products on labels to allow for informed consumer choices. The LED bulb market serves as a successful example where consumers are willing to pay higher upfront costs for long-term energy savings and durability. The current economic reliance on cheap, short-lived goods is compared to a pyramid scheme that generates excessive waste.

Dr. Richard Jacoby | The Toxic Effects of Sugar & The Corporate Food Conspiracy
• 34:45 - 37:18

Dr. Richard Jacoby | The Toxic Effects of Sugar & The Corporate Food Conspiracy

Nutrition Evidence Library, Congressional Influence

The Nutrition Evidence Library is described as a curated collection of data that only supports established government hypotheses regarding the food pyramid. Dr. Jacobi calls for transparency in food labeling, particularly for genetically modified organisms (GMOs). He suggests that the current lack of transparency is a deliberate effort by the food and pharmaceutical industries to maintain a $29 billion market for statin drugs.

nutrition evidence librarycongressgmolabeling transparencybernie sanders